000 | 01864 a2200505 4500 | ||
---|---|---|---|
005 | 20250517181919.0 | ||
264 | 0 | _c20180717 | |
008 | 201807s 0 0 eng d | ||
022 | _a1873-7064 | ||
024 | 7 |
_a10.1016/j.neuropharm.2017.10.020 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHussain, Al-Shimali M | |
245 | 0 | 0 |
_aMonoamine oxidase-B inhibitor protects degenerating spinal neurons, enhances nerve regeneration and functional recovery in sciatic nerve crush injury model. _h[electronic resource] |
260 |
_bNeuropharmacology _cJan 2018 |
||
300 |
_a231-243 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnterior Horn Cells _xdrug effects |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMonoamine Oxidase Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aMovement _xdrug effects |
650 | 0 | 4 |
_aMyelin Basic Protein _xmetabolism |
650 | 0 | 4 |
_aNerve Degeneration _xprevention & control |
650 | 0 | 4 |
_aNerve Fibers, Myelinated _xdrug effects |
650 | 0 | 4 |
_aNerve Regeneration _xdrug effects |
650 | 0 | 4 |
_aPain Threshold _xdrug effects |
650 | 0 | 4 |
_aPhosphopyruvate Hydratase _xmetabolism |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aRecovery of Function _xdrug effects |
650 | 0 | 4 |
_aSciatic Neuropathy _xcomplications |
650 | 0 | 4 |
_aSelegiline _xpharmacology |
650 | 0 | 4 |
_aSpinal Cord _xpathology |
650 | 0 | 4 |
_aWeight-Bearing _xphysiology |
700 | 1 | _aRenno, Waleed M | |
700 | 1 | _aSadek, Hanaa L | |
700 | 1 | _aKayali, Noura M | |
700 | 1 | _aAl-Salem, Aseel | |
700 | 1 | _aRao, Muddanna S | |
700 | 1 | _aKhan, Khalid M | |
773 | 0 |
_tNeuropharmacology _gvol. 128 _gp. 231-243 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuropharm.2017.10.020 _zAvailable from publisher's website |
999 |
_c27706711 _d27706711 |